These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25589938)

  • 21. Regulation of an epitope-tagged recombinant Rsk-1 S6 kinase by phorbol ester and erk/MAP kinase.
    Grove JR; Price DJ; Banerjee P; Balasubramanyam A; Ahmad MF; Avruch J
    Biochemistry; 1993 Aug; 32(30):7727-38. PubMed ID: 7688567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Actin Dysfunction Induces Cell Cycle Delay at G2/M with Sustained ERK and RSK Activation in IMR-90 Normal Human Fibroblasts.
    Shrestha D; Choi D; Song K
    Mol Cells; 2018 May; 41(5):436-443. PubMed ID: 29754473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial Expression, Purification and In Vitro Phosphorylation of Full-Length Ribosomal S6 Kinase 2 (RSK2).
    Utepbergenov D; Hennig PM; Derewenda U; Artamonov MV; Somlyo AV; Derewenda ZS
    PLoS One; 2016; 11(10):e0164343. PubMed ID: 27732676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defining the role of the RSK isoforms in cancer.
    Houles T; Roux PP
    Semin Cancer Biol; 2018 Feb; 48():53-61. PubMed ID: 28476656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel potent and selective inhibitors of p90 ribosomal S6 kinase reveal the heterogeneity of RSK function in MAPK-driven cancers.
    Aronchik I; Appleton BA; Basham SE; Crawford K; Del Rosario M; Doyle LV; Estacio WF; Lan J; Lindvall MK; Luu CA; Ornelas E; Venetsanakos E; Shafer CM; Jefferson AB
    Mol Cancer Res; 2014 May; 12(5):803-12. PubMed ID: 24554780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of ERK-RSK cascade in phenylephrine-induced phosphorylation of GATA4.
    Li T; Liu Z; Hu X; Ma K; Zhou C
    Biochim Biophys Acta; 2012 Feb; 1823(2):582-92. PubMed ID: 22227582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting ribosomal S6 kinases/Y-box binding protein-1 signaling improves cellular sensitivity to taxane in prostate cancer.
    Shiota M; Itsumi M; Yokomizo A; Takeuchi A; Imada K; Kashiwagi E; Inokuchi J; Tatsugami K; Uchiumi T; Naito S
    Prostate; 2014 Jun; 74(8):829-38. PubMed ID: 24729449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The RSK factors of activating the Ras/MAPK signaling cascade.
    Carriere A; Ray H; Blenis J; Roux PP
    Front Biosci; 2008 May; 13():4258-75. PubMed ID: 18508509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of actin-activated MgATPase activity of myosin II by phosphorylation with MAPK-activated protein kinase-1b (RSK-2).
    Suizu F; Ueda K; Iwasaki T; Murata-Hori M; Hosoya H
    J Biochem; 2000 Sep; 128(3):435-40. PubMed ID: 10965042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homology model of RSK2 N-terminal kinase domain, structure-based identification of novel RSK2 inhibitors, and preliminary common pharmacophore.
    Nguyen TL; Gussio R; Smith JA; Lannigan DA; Hecht SM; Scudiero DA; Shoemaker RH; Zaharevitz DW
    Bioorg Med Chem; 2006 Sep; 14(17):6097-105. PubMed ID: 16723234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flexible Enantiodivergent Synthesis and Biological Activity of Mannostatin Analogues, New Cyclitol Glycosidase Inhibitors.
    Nishimura Y; Umezawa Y; Adachi H; Kondo S; Takeuchi T
    J Org Chem; 1996 Jan; 61(2):480-488. PubMed ID: 11666964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of Potent and Selective RSK Inhibitors as Biological Probes.
    Jain R; Mathur M; Lan J; Costales A; Atallah G; Ramurthy S; Subramanian S; Setti L; Feucht P; Warne B; Doyle L; Basham S; Jefferson AB; Lindvall M; Appleton BA; Shafer CM
    J Med Chem; 2015 Sep; 58(17):6766-83. PubMed ID: 26270416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paving the way for targeting RSK in cancer.
    Romeo Y; Roux PP
    Expert Opin Ther Targets; 2011 Jan; 15(1):5-9. PubMed ID: 20958120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy.
    Sadoshima J; Izumo S
    Circ Res; 1995 Dec; 77(6):1040-52. PubMed ID: 7586215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions between FGFR2 and RSK2-implications for breast cancer prognosis.
    Czaplinska D; Mieczkowski K; Supernat A; Skladanowski AC; Kordek R; Biernat W; Zaczek AJ; Romanska HM; Sadej R
    Tumour Biol; 2016 Oct; 37(10):13721-13731. PubMed ID: 27476168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. de novo asymmetric synthesis of daumone via a palladium-catalyzed glycosylation.
    Guo H; O'doherty GA
    Org Lett; 2005 Sep; 7(18):3921-4. PubMed ID: 16119932
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Beck K; Hovhanyan A; Menegazzi P; Helfrich-Förster C; Raabe T
    Front Mol Neurosci; 2018; 11():122. PubMed ID: 29706866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concise and Stereodivergent Synthesis of Carbasugars Reveals Unexpected Structure-Activity Relationship (SAR) of SGLT2 Inhibition.
    Ng WL; Li HC; Lau KM; Chan AKN; Lau CB; Shing TKM
    Sci Rep; 2017 Jul; 7(1):5581. PubMed ID: 28717146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitogen-activated Swiss mouse 3T3 RSK kinases I and II are related to pp44mpk from sea star oocytes and participate in the regulation of pp90rsk activity.
    Chung J; Pelech SL; Blenis J
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4981-5. PubMed ID: 2052581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective Targeting of RSK Isoforms in Cancer.
    Casalvieri KA; Matheson CJ; Backos DS; Reigan P
    Trends Cancer; 2017 Apr; 3(4):302-312. PubMed ID: 28718440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.